Literature DB >> 27278162

Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma.

Yan Ling Wen1,2, Masatoshi Kudo1, Yasunori Minami1, Hobyung Chung1, Yoichiro Suetomi1, Hirokazu Onda1, Masayuki Kitano1, Toshihiko Kawasaki1, Kiyoshi Maekawa3.   

Abstract

PURPOSE: To investigate the usefulness of contrast-enhanced Agent Detection Imaging in assessing intratumoral vasculature in hepatocellular carcinoma.
MATERIALS AND METHODS: Fourteen hepatocellular carcinoma nodules in 11 patients were studied with contrast-enhanced Agent Detection Imaging, a wide-band color Doppler imaging method, employing, Levovist(®), a microbubble contrast agent. High acoustic power was used with contrast-enhanced Agent Detection Imaging. Intermittent transmission of Agent Detection Imaging was performed at intervals of 200, 500, and 350 milliseconds in the early arterial phase (10 to 40 seconds), late vascular phase (1 to 3 minutes) and postvascular phase (5 to 7 minutes), respectively. The results were compared with those of three-phase dynamic CT.
RESULTS: Intratumoral blood vessels in the early arterial phase and tumor parenchymal stain in the late vascular phase were depicted in 12 (88%) of the 14 hepatocellular carcinoma nodules, while all nodules were demonstrated as perfusion defect in the postvascular phase on contrast-enhanced Agent Detection Imaging. The results of Agent Detection Imaging, that were compared with those of dynamic CT, were all 100% : diagnostic sensitivity (12/12), specificity (2/2), and accurary (14/14).
CONCLUSION: Contrast-enhanced Agent Detection Imaging is a promising method for depicting intratumoral vascularity in hepatocellular carcinoma.

Entities:  

Keywords:  Doppler imaging; contrast medium; hepatocellular carcinoma; ultrasound; wide-band color

Year:  2003        PMID: 27278162     DOI: 10.1007/BF02481367

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  19 in total

1.  Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast.

Authors:  P N Burns; S R Wilson; D H Simpson
Journal:  Invest Radiol       Date:  2000-01       Impact factor: 6.016

2.  Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging.

Authors:  M Kudo
Journal:  Hepatogastroenterology       Date:  1998-08

Review 3.  Ultrasound contrast agents: basic principles.

Authors:  F Calliada; R Campani; O Bottinelli; A Bozzini; M G Sommaruga
Journal:  Eur J Radiol       Date:  1998-05       Impact factor: 3.528

4.  Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.

Authors:  H Ding; M Kudo; H Onda; Y Suetomi; Y Minami; K Maekawa
Journal:  Radiology       Date:  2001-08       Impact factor: 11.105

5.  Ultrasound contrast enhancement of tumours.

Authors:  D Cosgrove
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

6.  Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings.

Authors:  K Numata; K Tanaka; T Kiba; S Saito; M Ikeda; K Hara; N Tanaka; M Morimoto; S Iwase; H Sekihara
Journal:  J Ultrasound Med       Date:  2001-02       Impact factor: 2.153

7.  Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors.

Authors:  D Strobel; U Krodel; P Martus; E G Hahn; D Becker
Journal:  J Clin Ultrasound       Date:  2000-01       Impact factor: 0.910

Review 8.  Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions.

Authors:  M Kudo
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

9.  Contrast media in liver sonography: correlation with enhanced dynamic magnetic resonance imaging.

Authors:  C Zuiani; A Vasciaveo; C Del Frate; M Bazzocchi
Journal:  Eur J Radiol       Date:  1998-05       Impact factor: 3.528

10.  Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.

Authors:  A Y Kim; B I Choi; T K Kim; J K Han; E J Yun; K Y Lee; M C Han
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

View more
  1 in total

1.  Detection of hepatocellular carcinoma capsule by contrast-enhanced ultrasound using Levovist: correlations with pathological findings.

Authors:  Pabitra K Bhattacharjee; Akiko Saito; Michiyo Chiba; Hideo Katsuragawa; Ken Takasaki
Journal:  J Med Ultrason (2001)       Date:  2005-12       Impact factor: 1.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.